Epigenetic alterations driving platinum resistance relapse in high grade serous ovarian carcinoma at transcriptomic level

被引:0
|
作者
Ergasti, Raffaella [1 ]
Russo, Giorgia [1 ]
Lim, Mi Qi [2 ]
Giannone, Gaia [2 ]
Ennis, Darren P. [2 ]
Dye, Isabel Ca [2 ]
Mirza, Hasan B. [2 ]
Marchetti, Claudia [1 ]
Fagotti, Anna [1 ]
Scambia, Giovanni [1 ]
Mcneish, Iain [2 ]
机构
[1] Fdn Policlin Univ Agostino Gemelli, Dipartimento Sci Salute Donna Bambino & San Pubbl, IRCCS, Rome, Italy
[2] Imperial Coll London, London, England
关键词
D O I
10.1136/ijgc-2024-ESGO.987
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
702
引用
收藏
页码:A503 / A503
页数:1
相关论文
共 50 条
  • [1] Transcriptomic and epigenetic changes in ovarian high grade serous carcinoma after platinum treatment: results from an in vitro model
    Russo, Giorgia
    Ergasti, Raffaella
    Lim, Mi Qi
    Mirza, Hasan
    Giannone, Gaia
    Ennis, Darren P.
    Dye, Isabel C. A.
    Marchetti, Claudia
    Fagotti, Anna
    Scambia, Giovanni
    Mcneish, Iain
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A514 - A515
  • [2] TP53 mutations and the association with platinum resistance in high grade serous ovarian carcinoma
    Montemorano, Lauren
    Shultz, Zoey B.
    Farooque, Alma
    Hyun, Meredith
    Chappell, Richard J.
    Hartenbach, Ellen M.
    Lang, Jessica D.
    GYNECOLOGIC ONCOLOGY, 2024, 186 : 26 - 34
  • [3] A multi-omic analysis to identify epigenetic drivers of platinum-resistance in high-grade serous ovarian carcinoma models
    Adams, Kristin
    Moreno, Ryan
    Wendt, Jae-Rim
    Wood, Josie
    Roopra, Avtar
    Lang, Jessica D.
    CANCER RESEARCH, 2024, 84 (05)
  • [4] Evolution of platinum resistance in high-grade serous ovarian cancer
    Cooke, Susanna L.
    Brenton, James D.
    LANCET ONCOLOGY, 2011, 12 (12): : 1169 - 1174
  • [5] POSSIBLE EPIGENETIC CHANGES THAT COULD DRIVE PLATINUM RESISTANCE IN HIGH GRADE SEROUS OVARIAN CARCINOMA: DATA FROM AN IN-VITRO TREATMENT MODEL
    Ergasti, Raffaella
    Lim, Mi Qi
    Giannone, Gaia
    Ennis, Darren P.
    Dye, Isabel C. A.
    Mirza, Hasan B.
    Russo, Giorgia
    Fagotti, Anna
    Scambia, Giovanni
    Mcneish, Iain
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A369 - A370
  • [6] Characterizing DNA methylation patterns driving chemotherapy resistance in ovarian high-grade serous carcinoma
    Lahtinen, Alexandra
    Marchi, Giovanni
    Lavikka, Kari
    Micoli, Giulia
    Holmstrom, Susanna
    Pollanen, Elsi
    Maarala, Ilari
    Afenteva, Daria
    Li, Yilin
    Muranen, Taru A.
    Oikkonen, Jaana
    Huhtinen, Kaisa
    Virtanen, Anni
    Hynninen, Johanna
    Hakkinen, Antti
    Hautaniemi, Sampsa
    CANCER RESEARCH, 2024, 84 (05)
  • [7] Epigenomic signatures of acquired platinum resistance in high grade serous ovarian cancer
    Fang, Fang
    Cardenas, Horacio
    Jiang, Guanglong
    Perkins, Susan M.
    Zhang, Chi
    Keer, Harold
    Liu, Yunlong
    Matei, Daniela
    Nephew, Kenneth
    CANCER RESEARCH, 2018, 78 (13)
  • [8] CAF-associated signaling pathways are linked to platinum resistance in high-grade serous ovarian carcinoma
    Wessolly, Michael
    Mairinger, Elena
    Borchert, Sabrina
    Bankfalvi, Agnes
    Mach, Pawel
    Schmid, Kurt Werner
    Kimmig, Rainer
    Burderath, Paul
    Maringer, Fabian Dominik
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 255 - 256
  • [9] Reversing platinum resistance in high-grade serous ovarian carcinoma: targeting BRCA and the homologous recombination system
    Wiedemeyer, W. Ruprecht
    Beach, Jessica A.
    Karlan, Beth Y.
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [10] Potential Transcriptomic Biomarkers for Predicting Platinum-based Chemotherapy Resistance in Patients With High-grade Serous Ovarian Cancer
    Cocchi, Sara
    Lopacinska-Jorgensen, Joanna
    Hogdall, Estrid, V
    ANTICANCER RESEARCH, 2024, 44 (11) : 4691 - 4707